Ventricular Tachycardia Cohort
ConditionVentricular Tachycardia (VT)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBeijing Anzhen Hospital
About this trial
The goal of this observational study is to detect the long-term risk of a composite endpoint event in adult patients with ventricular tachycardia (VT) who are managed with catheter ablation or non-ablation management (including modern drug therapy and/or ICD therapy).
Eligibility criteria
Qualifiers
Sustained ventricular tachycardia (VT), defined as VT lasting ≥30 seconds or requiring intervention due to hemodynamic compromise within 30 seconds; or Clinically significant non-sustained VT (NSVT) where the treating clinician has determined that therapeutic intervention is necessary.
Disqualifiers
Concurrent participation in any interventional clinical trial that, in the judgment of the investigator, could interfere with the data collection or outcome assessment of this observational study.
Trial design
Treatments tested in this trial
- Intervention
Treatment groups
1,500 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov